scholarly article | Q13442814 |
P50 | author | Martin Rowe | Q37376494 |
Claire Shannon Lowe | Q95607355 | ||
P2093 | author name string | Sweta Raithatha | |
P2860 | cites work | A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE | Q28139998 |
Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H) | Q28286560 | ||
ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus | Q28471803 | ||
The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1 | Q28480586 | ||
Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo | Q28509550 | ||
Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells | Q28594415 | ||
Nuclear access and action of notch in vivo | Q28646384 | ||
The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter | Q33640213 | ||
Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. | Q33797347 | ||
Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells | Q33850400 | ||
Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner | Q33877497 | ||
Cellular MicroRNAs 200b and 429 Regulate the Epstein-Barr Virus Switch between Latency and Lytic Replication | Q34120915 | ||
Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development | Q34197865 | ||
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter | Q34355226 | ||
ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus | Q34461528 | ||
Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activa | Q34461819 | ||
Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells | Q34598541 | ||
Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency | Q35192797 | ||
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein | Q35648541 | ||
Soluble factors produced by activated CD4+ T cells modulate EBV latency | Q35749824 | ||
Regulation of lymphoid development, differentiation, and function by the Notch pathway. | Q36072476 | ||
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells | Q36173276 | ||
Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen | Q36390855 | ||
An auto-regulatory loop for EBV LMP2A involves activation of Notch | Q36528115 | ||
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. | Q36637195 | ||
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus | Q36688330 | ||
cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site | Q36804472 | ||
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo | Q37039112 | ||
Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. | Q37093134 | ||
Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection | Q37504372 | ||
Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. | Q37724159 | ||
The pathogenesis of Epstein-Barr virus persistent infection. | Q38107595 | ||
Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression | Q38319392 | ||
Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile | Q38321333 | ||
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells | Q38322174 | ||
Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes | Q38348963 | ||
Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters | Q39549769 | ||
Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2. | Q39582561 | ||
Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression | Q39603733 | ||
STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma | Q39650776 | ||
Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification | Q39852028 | ||
The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. | Q39860135 | ||
Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells | Q39876626 | ||
In vitro human T cell development directed by notch-ligand interactions | Q39997849 | ||
Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene | Q40062679 | ||
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia | Q40064626 | ||
IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines | Q40342745 | ||
Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. | Q40793575 | ||
Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells | Q42010316 | ||
ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells | Q42638304 | ||
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 | ||
Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells | Q45385554 | ||
Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays | Q45412384 | ||
Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma | Q45722302 | ||
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products | Q69621634 | ||
Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV | Q72756611 | ||
CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the | Q73802773 | ||
A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1 | Q73958442 | ||
Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation | Q79441801 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Epstein–Barr virus | Q6900 |
P304 | page(s) | 12065-12076 | |
P577 | publication date | 2014-08-13 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions | |
P478 | volume | 88 |
Q27321686 | Computational discovery of Epstein-Barr virus targeted human genes and signalling pathways |
Q38596350 | Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma |
Q36346985 | Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus |
Q28552335 | EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1 |
Q36736629 | Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites |
Q26998999 | Epstein-Barr virus and the origin of Hodgkin lymphoma |
Q56888557 | Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification |
Q59353945 | Molecular mechanisms of viral oncogenesis in humans |
Q37342493 | Notch Signaling Contributes to Liver Inflammation by Regulation of Interleukin-22-Producing Cells in Hepatitis B Virus Infection |
Q64086953 | Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders |
Q38258049 | The Epstein-Barr virus and the pathogenesis of lymphoma. |
Q91754323 | Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma |
Search more.